Inventor
GELFAND JEFFREY A
US15 patents
⚠️ This page may combine multiple inventors who share the name “GELFAND JEFFREY A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MASSACHUSETTS GEN HOSPITAL
7 patentsUS11453706B2Sep 27, 2022
HSP fusion protein with anti-chemorepellant agent for treatment of infectious disease
MASSACHUSETTS GEN HOSPITAL2 citations72
US11364264B2Jun 21, 2022
Ex vivo antigen-presenting cells or activated CD-positive T cells for treatment of cancer
MASSACHUSETTS GEN HOSPITAL2 citations72
US11325951B2May 10, 2022
HSP fusion protein with anti-chemorepellant agent for treatment of cancer
MASSACHUSETTS GEN HOSPITAL2 citations72
US11718683B2Aug 8, 2023
Antigen-binding fusion proteins with modified HSP70 domains
MASSACHUSETTS GEN HOSPITAL2 citations67
US12540165B2Feb 3, 2026
HSP fusion protein with anti-chemorepellant agent for treatment of cancer
MASSACHUSETTS GEN HOSPITAL0 citations62
US11135445B2Oct 5, 2021
Antimicrobial photodynamic inactivation procedure and system
MASSACHUSETTS GEN HOSPITAL0 citations55
US10800837B2Oct 13, 2020
Immunotherapies employing self-assembling vaccines
MASSACHUSETTS GEN HOSPITAL0 citations46
GELFAND JEFFREY A
3 patentsUS8435494B2May 7, 2013
Mesothelin antibody protein fusions and methods of use
GELFAND JEFFREY A18 citations90
US8143387B2Mar 27, 2012
Engineered antibody-stress protein fusions
GELFAND JEFFREY A7 citations82
US9527906B2Dec 27, 2016
Immunotherapies employing self-assembling vaccines
GELFAND JEFFREY A4 citations66